iShares Biotechnology ETF (IBB)

NASDAQ Financial Services Asset Management

iShares Biotechnology ETF operates in the Asset Management industry of the Financial Services sector, headquartered in San Francisco, CA, US. The stock last traded at $200.72, up 0.49% on the session, giving a market capitalisation of $9.92B. Its beta of 0.70 implies it has historically moved less than the broad market.

The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U.S. biotechnology sector.

iShares Biotechnology ETF is most often compared with the following Financial Services names: